DUAL CLK/CDK1 INHIBITORS FOR CANCER TREATMENT Application EP-4086257-A1 European Patent Office 09 Nov 2022
PROCESS FOR EXPLOITING SYNTHETIC LETHALITY BASED ON OVEREXPRESSION OF MYC ONCOGENE Application EP-3500263-A4 European Patent Office 18 Mar 2020
DUAL CLK/CDK1 INHIBITORS FOR CANCER TREATMENT Application WO-2018064545-A1 World Intellectual Property Organisation (WIPO) 05 Apr 2018